COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,974 Articles (22,604 medRxiv, 8,370 bioRxiv)

Most recent first Previous |  Page 708: Articles 7071-7080  | Next

Efficient direct and limited environmental transmission of SARS-CoV-2 lineage B.1.22 in domestic cats
Gerhards, N. M., Gonzales, J. L., Vreman, S., Ravesloot, L., van den Brand, J. M. A., Doekes, H., Egberink, H., Stegeman, A. J., Oreshkova, N., van der Poel, W. H. M., de Jong, M. C. M.
10.1101/2022.06.17.496600 — Posted: 2022-06-19
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Moulana, A., Dupic, T., Phillips, A. M., Chang, J., Nieves, S., Roffler, A. A., Greaney, A. J., Starr, T. N., Bloom, J. D., Desai, M. M.
10.1101/2022.06.17.496635 — Posted: 2022-06-19
Estimating RSV seasonality from pandemic disruptions: a modelling study
Krauer, F., Fjelde, T. E., Koltai, M., Hodgson, D., Treskova-Schwarzbach, M., Harvey, C., Jit, M., Wichmann, O., Harder, T., Flasche, S.
10.1101/2022.06.18.22276591 — Posted: 2022-06-19
Is COVID-19 seasonal? A time series modeling approach
Wiemken, T. L., Khan, F., Nguyen, J. L., Jodar, L., McLaughlin, J. M.
10.1101/2022.06.17.22276570 — Posted: 2022-06-19
An update on oral clinical courses among patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study
Gebretsadik, H. G.
10.1101/2022.06.16.22276533 — Posted: 2022-06-19
A patient-centric characterization of systemic recovery from SARS-CoV-2 infection
Ruffieux, H., Hanson, A., Lodge, S., Lawler, N., Whiley, L., Gray, N., Nolan, T., Bergamaschi, L., Mescia, F., CITIID-NIHR COVID BioResource Collaboration, , Kingston, N., Bradley, J., Holmes, E., Wist, J., Nicholson, J., Lyons, P., Smith, K., Richardson, S., Bantug, G., Hess, C.
10.1101/2022.06.18.22276437 — Posted: 2022-06-19
Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study
Chen, Z., Deng, X., Fang, L., Sun, K., Wu, Y., Che, T., Zou, J., Cai, J., Liu, H., Wang, Y., Wang, T., Tian, Y., Zheng, N., Yan, X., Sun, R., Xu, X., Zhou, X., Ge, S., Liang, Y., Yi, L., Yang, J., Zhang, J., Ajelli, M., Yu, H.
10.1101/2022.06.11.22276273 — Posted: 2022-06-18
How do Urban Factors Control the Severity of COVID-19?
Roxon, J., Dumont, M.-S., Vilain, E., Pellenq, R.
10.1101/2022.06.17.22276576 — Posted: 2022-06-18
Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients During the Omicron Phase
Aggarwal, N., Beaty, L. E., Bennett, T. D., Carlson, N. E., Ginde, A. A.
10.1101/2022.06.17.22276575 — Posted: 2022-06-18
SARS-CoV-2 infection-induced immunity and the duration of viral shedding: results from a Nicaraguan household cohort study
Maier, H. E., Plazaola, M., Lopez, R., Sanchez, N., Saborio, S., Ojeda, S., Barilla, C., Kuan, G., Balmaseda, A., Gordon, A.
10.1101/2022.06.17.22276565 — Posted: 2022-06-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).